Почетна › Колоректални карцином › Kolorado › Denver
Kliničke studije za Колоректални карцином u gradu Denver, CO
22 studija za Колоректални карцином traži učesnike na lokacijama u gradu Denver i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
Тражи се учесникФаза 1
- Sarah Cannon Research Institute at HealthONE, Denver
The Vanguard Study: Testing a New Way to Screen for Cancer
Тражи се учесникЗдраве особе су добродошле
- Kaiser Permanente-Franklin, Denver
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Тражи се учесникФаза 3
- Clinical Study Site, Denver
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
- AdventHealth Porter, Denver
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Тражи се учесникОпсервациона студија
- Kaiser Permanente-Franklin, Denver
- Colorado Blood Cancer Institute, Denver
- Rocky Mountain Cancer Centers-Midtown, Denver
- и још 1
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Тражи се учесникФаза 3
- Rocky Mountain Cancer Centers, Denver
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Тражи се учесникФаза 3
- Rocky Mountain Cancer Centers, Denver
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
Тражи се учесникФаза 1
- Sarah Cannon Cancer Institute at HealthONE, Denver
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1/2
- Sarah Cannon Research Institute at HealthONE, Denver
A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9
Тражи се учесникФаза 1/2
- SCRI at HCA Health One, Denver
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
Тражи се учесникФаза 1
- Sarah Cannon Research Institute at HealthONE, Denver
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Тражи се учесникФаза 3
- Intermountain Health Cancer Center Saint Joseph, Denver
- Intermountain Health Saint Joseph Hospital - Research Office, Denver
- Intermountain Health Saint Joseph Hospital, Denver
- и још 3
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Тражи се учесникФаза 1/2
- Rocky Mountain Cancer Center, Denver
Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
Тражи се учесникФаза 1/2
- Sarah Cannon Research Institute (SCRI), Denver
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
Тражи се учесникФаза 1
- SCRI Denver, Denver
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
Тражи се учесникФаза 1
- Sarah Cannon Research Institute, Denver
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
Тражи се учесникФаза 3
- Rocky Mountain Cancer Centers, LLP, Denver
- Rocky Mountain Cancer Centers, LLP, Denver
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
Тражи се учесникФаза 1
- Sarah Cannon Research Institue At Healthone, Denver
A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
Тражи се учесникФаза 2
- Rocky Mountain Cancer Center - Primary, Denver
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
Тражи се учесникФаза 1/2
- SCRI - Denver, Denver
Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
- Department of Medicine-Gastroenterology, Denver Veterans Affairs Medical Center, University of Colorado Hospital, Denver
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1/2
- Sarah Cannon Research Institute at HealthONE, Denver
Studije za Колоректални карцином u drugim gradovima
- Houston, TX101 студија
- New York City, NY86 студија
- Nashville, TN67 студија
- Boston, MA62 студија
- Los Angeles, CA61 студија
- Arlington, VA54 студија
- St. Louis, MO51 студија
- San Antonio, TX43 студија
- Philadelphia, PA41 студија
- Grand Rapids, MI40 студија
- Baldwin Park, CA37 студија
- Tampa, FL36 студија
Ostale studije u gradu Denver
- Рак дојке26 студија
- Многи мијелом26 студија
- Немалоклетни карцином плућа25 студија
- Метастатски карцином25 студија
- Меланом19 студија
- Рак простате19 студија
- Рак јајника17 студија
- Карцином ендометријума15 студија
- Рак (све врсте)15 студија
- Рак плућа15 студија
- Не-Ходжкинов лимфом14 студија
- Рак панкреаса13 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.